Europe Facial Fat Transfer Market (2019-2025)
The Europe Facial Fat Transfer Market would witness market growth of 10% CAGR during the forecast period (2019-2025).
Europe is expected to record a significant market share owing to the increased demand for facial fat transfer across the European countries. In Europe, most countries have a refund policy, which is a key driver of market growth. In addition, there is an increasing demand for minimally invasive cosmetic surgeries that enhance the youthfulness and demand for dermal fillers in this region.
Fat Transfer is not just a bioinert material, but a metabolic active substance and a live graft. Facial Fat Transfer procedures are therefore done only by experts or cosmetic surgeons. The procedure consists of collecting small amounts of fat from other parts of the body, such as the thighs, abdomen or hips, and injecting it into areas of the face that are depleted. It reduces lines and reshapes the face, improving the overall youthfulness of facial appearance.
During a surgical procedure, a small amount of fat obtained from other parts of the body, such as the abdomen, thighs, or hips, is typically inserted into various areas of the face with reduced volume. Body fat is highly compatible and well accepted by human skin and gives a natural look. The recent introduction of liposuction makes fat collection simpler. Advanced methods have made the process of removing fat from parts of the body and injecting it into particular parts of the body's face or other parts secure. Technically, this process is referred to as autologous facial fat transfer.
Based on Donor Site, the market is segmented into Flank, Thigh and Abdomen. Based on End Use, the market is segmented into Clinics & surgery centers and Hospitals. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Allergan PLC, Integra LifeSciences Holdings Corporation, Bausch Health Companies, Inc., Ipsen Pharma Biotech SAS, Ranfac Corporation, Cytori Therapeutics, Inc., Suneva Medical, Inc., Dr. Korman Laboratories Ltd., Scivision Biotech, Inc., and Teoxane Laboratories SA.
SCOPE OF THE STUDY
Market Segmentation:
By Donor Site
Europe is expected to record a significant market share owing to the increased demand for facial fat transfer across the European countries. In Europe, most countries have a refund policy, which is a key driver of market growth. In addition, there is an increasing demand for minimally invasive cosmetic surgeries that enhance the youthfulness and demand for dermal fillers in this region.
Fat Transfer is not just a bioinert material, but a metabolic active substance and a live graft. Facial Fat Transfer procedures are therefore done only by experts or cosmetic surgeons. The procedure consists of collecting small amounts of fat from other parts of the body, such as the thighs, abdomen or hips, and injecting it into areas of the face that are depleted. It reduces lines and reshapes the face, improving the overall youthfulness of facial appearance.
During a surgical procedure, a small amount of fat obtained from other parts of the body, such as the abdomen, thighs, or hips, is typically inserted into various areas of the face with reduced volume. Body fat is highly compatible and well accepted by human skin and gives a natural look. The recent introduction of liposuction makes fat collection simpler. Advanced methods have made the process of removing fat from parts of the body and injecting it into particular parts of the body's face or other parts secure. Technically, this process is referred to as autologous facial fat transfer.
Based on Donor Site, the market is segmented into Flank, Thigh and Abdomen. Based on End Use, the market is segmented into Clinics & surgery centers and Hospitals. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Allergan PLC, Integra LifeSciences Holdings Corporation, Bausch Health Companies, Inc., Ipsen Pharma Biotech SAS, Ranfac Corporation, Cytori Therapeutics, Inc., Suneva Medical, Inc., Dr. Korman Laboratories Ltd., Scivision Biotech, Inc., and Teoxane Laboratories SA.
SCOPE OF THE STUDY
Market Segmentation:
By Donor Site
- Flank
- Thigh
- Abdomen
- Clinics & surgery centers
- Hospitals
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Allergan PLC
- Integra LifeSciences Holdings Corporation
- Bausch Health Companies, Inc.
- Ipsen Pharma Biotech SAS
- Ranfac Corporation
- Cytori Therapeutics, Inc.
- Suneva Medical, Inc.
- Dr. Korman Laboratories Ltd.
- Scivision Biotech, Inc.
- Teoxane Laboratories SA
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Facial Fat Transfer Market, by Donor Site
1.4.2 Europe Facial Fat Transfer Market, by End Use
1.4.3 Europe Facial Fat Transfer Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. EUROPE FACIAL FAT TRANSFER MARKET BY DONOR SITE
3.1 Europe Flank Facial Fat Transfer Market by Country
3.2 Europe Thigh Facial Fat Transfer Market by Country
3.3 Europe Abdomen Facial Fat Transfer Market by Country
CHAPTER 4. EUROPE FACIAL FAT TRANSFER MARKET BY END-USE
4.1 Europe Clinics & surgery centers Market by Country
4.2 Europe Hospitals Market by Country
CHAPTER 5. EUROPE FACIAL FAT TRANSFER MARKET BY COUNTRY
5.1 Germany Facial Fat Transfer Market
5.1.1 Germany Facial Fat Transfer Market by Donor Site
5.1.2 Germany Facial Fat Transfer Market by End-Use
5.2 UK Facial Fat Transfer Market
5.2.1 UK Facial Fat Transfer Market by Donor Site
5.2.2 UK Facial Fat Transfer Market by End-Use
5.3 France Facial Fat Transfer Market
5.3.1 France Facial Fat Transfer Market by Donor Site
5.3.2 France Facial Fat Transfer Market by End-Use
5.4 Russia Facial Fat Transfer Market
5.4.1 Russia Facial Fat Transfer Market by Donor Site
5.4.2 Russia Facial Fat Transfer Market by End-Use
5.5 Spain Facial Fat Transfer Market
5.5.1 Spain Facial Fat Transfer Market by Donor Site
5.5.2 Spain Facial Fat Transfer Market by End-Use
5.6 Italy Facial Fat Transfer Market
5.6.1 Italy Facial Fat Transfer Market by Donor Site
5.6.2 Italy Facial Fat Transfer Market by End-Use
5.7 Rest of Europe Facial Fat Transfer Market
5.7.1 Rest of Europe Facial Fat Transfer Market by Donor Site
5.7.2 Rest of Europe Facial Fat Transfer Market by End-Use
CHAPTER 6. COMPANY PROFILES
6.1 Allergan PLC
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Acquisition and Mergers:
6.2 Integra LifeSciences Holdings Corporation
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Bausch Health Companies, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.4 Ipsen Pharma Biotech SAS
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.5 Ranfac Corporation
6.5.1 Company Overview
6.6 Cytori Therapeutics, Inc.
6.6.1 Company Overview
6.7 Suneva Medical, Inc.
6.7.1 Company Overview
6.7.2 Recent strategies and developments:
6.7.2.1 Partnerships, Collaborations, and Agreements:
6.8 Dr. Korman Laboratories Ltd.
6.8.1 Company Overview
6.9 Scivision Biotech, Inc.
6.9.1 Company Overview
6.1 Teoxane Laboratories SA
6.10.1 Company Overview
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Facial Fat Transfer Market, by Donor Site
1.4.2 Europe Facial Fat Transfer Market, by End Use
1.4.3 Europe Facial Fat Transfer Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. EUROPE FACIAL FAT TRANSFER MARKET BY DONOR SITE
3.1 Europe Flank Facial Fat Transfer Market by Country
3.2 Europe Thigh Facial Fat Transfer Market by Country
3.3 Europe Abdomen Facial Fat Transfer Market by Country
CHAPTER 4. EUROPE FACIAL FAT TRANSFER MARKET BY END-USE
4.1 Europe Clinics & surgery centers Market by Country
4.2 Europe Hospitals Market by Country
CHAPTER 5. EUROPE FACIAL FAT TRANSFER MARKET BY COUNTRY
5.1 Germany Facial Fat Transfer Market
5.1.1 Germany Facial Fat Transfer Market by Donor Site
5.1.2 Germany Facial Fat Transfer Market by End-Use
5.2 UK Facial Fat Transfer Market
5.2.1 UK Facial Fat Transfer Market by Donor Site
5.2.2 UK Facial Fat Transfer Market by End-Use
5.3 France Facial Fat Transfer Market
5.3.1 France Facial Fat Transfer Market by Donor Site
5.3.2 France Facial Fat Transfer Market by End-Use
5.4 Russia Facial Fat Transfer Market
5.4.1 Russia Facial Fat Transfer Market by Donor Site
5.4.2 Russia Facial Fat Transfer Market by End-Use
5.5 Spain Facial Fat Transfer Market
5.5.1 Spain Facial Fat Transfer Market by Donor Site
5.5.2 Spain Facial Fat Transfer Market by End-Use
5.6 Italy Facial Fat Transfer Market
5.6.1 Italy Facial Fat Transfer Market by Donor Site
5.6.2 Italy Facial Fat Transfer Market by End-Use
5.7 Rest of Europe Facial Fat Transfer Market
5.7.1 Rest of Europe Facial Fat Transfer Market by Donor Site
5.7.2 Rest of Europe Facial Fat Transfer Market by End-Use
CHAPTER 6. COMPANY PROFILES
6.1 Allergan PLC
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Acquisition and Mergers:
6.2 Integra LifeSciences Holdings Corporation
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Bausch Health Companies, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.4 Ipsen Pharma Biotech SAS
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.5 Ranfac Corporation
6.5.1 Company Overview
6.6 Cytori Therapeutics, Inc.
6.6.1 Company Overview
6.7 Suneva Medical, Inc.
6.7.1 Company Overview
6.7.2 Recent strategies and developments:
6.7.2.1 Partnerships, Collaborations, and Agreements:
6.8 Dr. Korman Laboratories Ltd.
6.8.1 Company Overview
6.9 Scivision Biotech, Inc.
6.9.1 Company Overview
6.1 Teoxane Laboratories SA
6.10.1 Company Overview
LIST OF TABLES
TABLE 1 EUROPE FACIAL FAT TRANSFER MARKET, 2015 - 2018, USD MILLION
TABLE 2 EUROPE FACIAL FAT TRANSFER MARKET, 2019 - 2025, USD MILLION
TABLE 3 EUROPE FACIAL FAT TRANSFER MARKET BY DONOR SITE, 2015 - 2018, USD MILLION
TABLE 4 EUROPE FACIAL FAT TRANSFER MARKET BY DONOR SITE, 2019 - 2025, USD MILLION
TABLE 5 EUROPE FLANK FACIAL FAT TRANSFER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 6 EUROPE FLANK FACIAL FAT TRANSFER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 7 EUROPE THIGH FACIAL FAT TRANSFER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 8 EUROPE THIGH FACIAL FAT TRANSFER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 9 EUROPE ABDOMEN FACIAL FAT TRANSFER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 EUROPE ABDOMEN FACIAL FAT TRANSFER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 EUROPE FACIAL FAT TRANSFER MARKET BY END-USE, 2015 - 2018, USD MILLION
TABLE 12 EUROPE FACIAL FAT TRANSFER MARKET BY END-USE, 2019 - 2025, USD MILLION
TABLE 13 EUROPE CLINICS & SURGERY CENTERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 EUROPE CLINICS & SURGERY CENTERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 EUROPE HOSPITALS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 16 EUROPE HOSPITALS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 17 EUROPE FACIAL FAT TRANSFER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 18 EUROPE FACIAL FAT TRANSFER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 19 GERMANY FACIAL FAT TRANSFER MARKET, 2015 - 2018, USD MILLION
TABLE 20 GERMANY FACIAL FAT TRANSFER MARKET, 2019 - 2025, USD MILLION
TABLE 21 GERMANY FACIAL FAT TRANSFER MARKET BY DONOR SITE, 2015 - 2018, USD MILLION
TABLE 22 GERMANY FACIAL FAT TRANSFER MARKET BY DONOR SITE, 2019 - 2025, USD MILLION
TABLE 23 GERMANY FACIAL FAT TRANSFER MARKET BY END-USE, 2015 - 2018, USD MILLION
TABLE 24 GERMANY FACIAL FAT TRANSFER MARKET BY END-USE, 2019 - 2025, USD MILLION
TABLE 25 UK FACIAL FAT TRANSFER MARKET, 2015 - 2018, USD MILLION
TABLE 26 UK FACIAL FAT TRANSFER MARKET, 2019 - 2025, USD MILLION
TABLE 27 UK FACIAL FAT TRANSFER MARKET BY DONOR SITE, 2015 - 2018, USD MILLION
TABLE 28 UK FACIAL FAT TRANSFER MARKET BY DONOR SITE, 2019 - 2025, USD MILLION
TABLE 29 UK FACIAL FAT TRANSFER MARKET BY END-USE, 2015 - 2018, USD MILLION
TABLE 30 UK FACIAL FAT TRANSFER MARKET BY END-USE, 2019 - 2025, USD MILLION
TABLE 31 FRANCE FACIAL FAT TRANSFER MARKET, 2015 - 2018, USD MILLION
TABLE 32 FRANCE FACIAL FAT TRANSFER MARKET, 2019 - 2025, USD MILLION
TABLE 33 FRANCE FACIAL FAT TRANSFER MARKET BY DONOR SITE, 2015 - 2018, USD MILLION
TABLE 34 FRANCE FACIAL FAT TRANSFER MARKET BY DONOR SITE, 2019 - 2025, USD MILLION
TABLE 35 FRANCE FACIAL FAT TRANSFER MARKET BY END-USE, 2015 - 2018, USD MILLION
TABLE 36 FRANCE FACIAL FAT TRANSFER MARKET BY END-USE, 2019 - 2025, USD MILLION
TABLE 37 RUSSIA FACIAL FAT TRANSFER MARKET, 2015 - 2018, USD MILLION
TABLE 38 RUSSIA FACIAL FAT TRANSFER MARKET, 2019 - 2025, USD MILLION
TABLE 39 RUSSIA FACIAL FAT TRANSFER MARKET BY DONOR SITE, 2015 - 2018, USD MILLION
TABLE 40 RUSSIA FACIAL FAT TRANSFER MARKET BY DONOR SITE, 2019 - 2025, USD MILLION
TABLE 41 RUSSIA FACIAL FAT TRANSFER MARKET BY END-USE, 2015 - 2018, USD MILLION
TABLE 42 RUSSIA FACIAL FAT TRANSFER MARKET BY END-USE, 2019 - 2025, USD MILLION
TABLE 43 SPAIN FACIAL FAT TRANSFER MARKET, 2015 - 2018, USD MILLION
TABLE 44 SPAIN FACIAL FAT TRANSFER MARKET, 2019 - 2025, USD MILLION
TABLE 45 SPAIN FACIAL FAT TRANSFER MARKET BY DONOR SITE, 2015 - 2018, USD MILLION
TABLE 46 SPAIN FACIAL FAT TRANSFER MARKET BY DONOR SITE, 2019 - 2025, USD MILLION
TABLE 47 SPAIN FACIAL FAT TRANSFER MARKET BY END-USE, 2015 - 2018, USD MILLION
TABLE 48 SPAIN FACIAL FAT TRANSFER MARKET BY END-USE, 2019 - 2025, USD MILLION
TABLE 49 ITALY FACIAL FAT TRANSFER MARKET, 2015 - 2018, USD MILLION
TABLE 50 ITALY FACIAL FAT TRANSFER MARKET, 2019 - 2025, USD MILLION
TABLE 51 ITALY FACIAL FAT TRANSFER MARKET BY DONOR SITE, 2015 - 2018, USD MILLION
TABLE 52 ITALY FACIAL FAT TRANSFER MARKET BY DONOR SITE, 2019 - 2025, USD MILLION
TABLE 53 ITALY FACIAL FAT TRANSFER MARKET BY END-USE, 2015 - 2018, USD MILLION
TABLE 54 ITALY FACIAL FAT TRANSFER MARKET BY END-USE, 2019 - 2025, USD MILLION
TABLE 55 REST OF EUROPE FACIAL FAT TRANSFER MARKET, 2015 - 2018, USD MILLION
TABLE 56 REST OF EUROPE FACIAL FAT TRANSFER MARKET, 2019 - 2025, USD MILLION
TABLE 57 REST OF EUROPE FACIAL FAT TRANSFER MARKET BY DONOR SITE, 2015 - 2018, USD MILLION
TABLE 58 REST OF EUROPE FACIAL FAT TRANSFER MARKET BY DONOR SITE, 2019 - 2025, USD MILLION
TABLE 59 REST OF EUROPE FACIAL FAT TRANSFER MARKET BY END-USE, 2015 - 2018, USD MILLION
TABLE 60 REST OF EUROPE FACIAL FAT TRANSFER MARKET BY END-USE, 2019 - 2025, USD MILLION
TABLE 61 KEY INFORMATION – ALLERGAN PLC
TABLE 62 KEY INFORMATION – INTEGRA LIFESCIENCES HOLDINGS CORPORATION
TABLE 63 KEY INFORMATION – BAUSCH HEALTH COMPANIES INC.
TABLE 64 KEY INFORMATION – IPSEN PHARMA BIOTECH SAS
TABLE 65 KEY INFORMATION – RANFAC CORPORATION
TABLE 66 KEY INFORMATION –CYTORI THERAPEUTICS, INC.
TABLE 67 KEY INFORMATION – SUNEVA MEDICAL, INC.
TABLE 68 KEY INFORMATION – DR. KORMAN LABORATORIES LTD.
TABLE 69 KEY INFORMATION – SCIVISION BIOTECH, INC.
TABLE 70 KEY INFORMATION – TEOXANE LABORATORIES SA
TABLE 1 EUROPE FACIAL FAT TRANSFER MARKET, 2015 - 2018, USD MILLION
TABLE 2 EUROPE FACIAL FAT TRANSFER MARKET, 2019 - 2025, USD MILLION
TABLE 3 EUROPE FACIAL FAT TRANSFER MARKET BY DONOR SITE, 2015 - 2018, USD MILLION
TABLE 4 EUROPE FACIAL FAT TRANSFER MARKET BY DONOR SITE, 2019 - 2025, USD MILLION
TABLE 5 EUROPE FLANK FACIAL FAT TRANSFER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 6 EUROPE FLANK FACIAL FAT TRANSFER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 7 EUROPE THIGH FACIAL FAT TRANSFER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 8 EUROPE THIGH FACIAL FAT TRANSFER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 9 EUROPE ABDOMEN FACIAL FAT TRANSFER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 EUROPE ABDOMEN FACIAL FAT TRANSFER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 EUROPE FACIAL FAT TRANSFER MARKET BY END-USE, 2015 - 2018, USD MILLION
TABLE 12 EUROPE FACIAL FAT TRANSFER MARKET BY END-USE, 2019 - 2025, USD MILLION
TABLE 13 EUROPE CLINICS & SURGERY CENTERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 EUROPE CLINICS & SURGERY CENTERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 EUROPE HOSPITALS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 16 EUROPE HOSPITALS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 17 EUROPE FACIAL FAT TRANSFER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 18 EUROPE FACIAL FAT TRANSFER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 19 GERMANY FACIAL FAT TRANSFER MARKET, 2015 - 2018, USD MILLION
TABLE 20 GERMANY FACIAL FAT TRANSFER MARKET, 2019 - 2025, USD MILLION
TABLE 21 GERMANY FACIAL FAT TRANSFER MARKET BY DONOR SITE, 2015 - 2018, USD MILLION
TABLE 22 GERMANY FACIAL FAT TRANSFER MARKET BY DONOR SITE, 2019 - 2025, USD MILLION
TABLE 23 GERMANY FACIAL FAT TRANSFER MARKET BY END-USE, 2015 - 2018, USD MILLION
TABLE 24 GERMANY FACIAL FAT TRANSFER MARKET BY END-USE, 2019 - 2025, USD MILLION
TABLE 25 UK FACIAL FAT TRANSFER MARKET, 2015 - 2018, USD MILLION
TABLE 26 UK FACIAL FAT TRANSFER MARKET, 2019 - 2025, USD MILLION
TABLE 27 UK FACIAL FAT TRANSFER MARKET BY DONOR SITE, 2015 - 2018, USD MILLION
TABLE 28 UK FACIAL FAT TRANSFER MARKET BY DONOR SITE, 2019 - 2025, USD MILLION
TABLE 29 UK FACIAL FAT TRANSFER MARKET BY END-USE, 2015 - 2018, USD MILLION
TABLE 30 UK FACIAL FAT TRANSFER MARKET BY END-USE, 2019 - 2025, USD MILLION
TABLE 31 FRANCE FACIAL FAT TRANSFER MARKET, 2015 - 2018, USD MILLION
TABLE 32 FRANCE FACIAL FAT TRANSFER MARKET, 2019 - 2025, USD MILLION
TABLE 33 FRANCE FACIAL FAT TRANSFER MARKET BY DONOR SITE, 2015 - 2018, USD MILLION
TABLE 34 FRANCE FACIAL FAT TRANSFER MARKET BY DONOR SITE, 2019 - 2025, USD MILLION
TABLE 35 FRANCE FACIAL FAT TRANSFER MARKET BY END-USE, 2015 - 2018, USD MILLION
TABLE 36 FRANCE FACIAL FAT TRANSFER MARKET BY END-USE, 2019 - 2025, USD MILLION
TABLE 37 RUSSIA FACIAL FAT TRANSFER MARKET, 2015 - 2018, USD MILLION
TABLE 38 RUSSIA FACIAL FAT TRANSFER MARKET, 2019 - 2025, USD MILLION
TABLE 39 RUSSIA FACIAL FAT TRANSFER MARKET BY DONOR SITE, 2015 - 2018, USD MILLION
TABLE 40 RUSSIA FACIAL FAT TRANSFER MARKET BY DONOR SITE, 2019 - 2025, USD MILLION
TABLE 41 RUSSIA FACIAL FAT TRANSFER MARKET BY END-USE, 2015 - 2018, USD MILLION
TABLE 42 RUSSIA FACIAL FAT TRANSFER MARKET BY END-USE, 2019 - 2025, USD MILLION
TABLE 43 SPAIN FACIAL FAT TRANSFER MARKET, 2015 - 2018, USD MILLION
TABLE 44 SPAIN FACIAL FAT TRANSFER MARKET, 2019 - 2025, USD MILLION
TABLE 45 SPAIN FACIAL FAT TRANSFER MARKET BY DONOR SITE, 2015 - 2018, USD MILLION
TABLE 46 SPAIN FACIAL FAT TRANSFER MARKET BY DONOR SITE, 2019 - 2025, USD MILLION
TABLE 47 SPAIN FACIAL FAT TRANSFER MARKET BY END-USE, 2015 - 2018, USD MILLION
TABLE 48 SPAIN FACIAL FAT TRANSFER MARKET BY END-USE, 2019 - 2025, USD MILLION
TABLE 49 ITALY FACIAL FAT TRANSFER MARKET, 2015 - 2018, USD MILLION
TABLE 50 ITALY FACIAL FAT TRANSFER MARKET, 2019 - 2025, USD MILLION
TABLE 51 ITALY FACIAL FAT TRANSFER MARKET BY DONOR SITE, 2015 - 2018, USD MILLION
TABLE 52 ITALY FACIAL FAT TRANSFER MARKET BY DONOR SITE, 2019 - 2025, USD MILLION
TABLE 53 ITALY FACIAL FAT TRANSFER MARKET BY END-USE, 2015 - 2018, USD MILLION
TABLE 54 ITALY FACIAL FAT TRANSFER MARKET BY END-USE, 2019 - 2025, USD MILLION
TABLE 55 REST OF EUROPE FACIAL FAT TRANSFER MARKET, 2015 - 2018, USD MILLION
TABLE 56 REST OF EUROPE FACIAL FAT TRANSFER MARKET, 2019 - 2025, USD MILLION
TABLE 57 REST OF EUROPE FACIAL FAT TRANSFER MARKET BY DONOR SITE, 2015 - 2018, USD MILLION
TABLE 58 REST OF EUROPE FACIAL FAT TRANSFER MARKET BY DONOR SITE, 2019 - 2025, USD MILLION
TABLE 59 REST OF EUROPE FACIAL FAT TRANSFER MARKET BY END-USE, 2015 - 2018, USD MILLION
TABLE 60 REST OF EUROPE FACIAL FAT TRANSFER MARKET BY END-USE, 2019 - 2025, USD MILLION
TABLE 61 KEY INFORMATION – ALLERGAN PLC
TABLE 62 KEY INFORMATION – INTEGRA LIFESCIENCES HOLDINGS CORPORATION
TABLE 63 KEY INFORMATION – BAUSCH HEALTH COMPANIES INC.
TABLE 64 KEY INFORMATION – IPSEN PHARMA BIOTECH SAS
TABLE 65 KEY INFORMATION – RANFAC CORPORATION
TABLE 66 KEY INFORMATION –CYTORI THERAPEUTICS, INC.
TABLE 67 KEY INFORMATION – SUNEVA MEDICAL, INC.
TABLE 68 KEY INFORMATION – DR. KORMAN LABORATORIES LTD.
TABLE 69 KEY INFORMATION – SCIVISION BIOTECH, INC.
TABLE 70 KEY INFORMATION – TEOXANE LABORATORIES SA
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 1 METHODOLOGY FOR THE RESEARCH
